This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Collection of Blood and Bone Marrow From Patients With Aplastic Anemia for Analysis of Adhesion Molecules, Chemokines and Their Receptors

This study has been withdrawn prior to enrollment.
(No eligible patient was enrolled.)
Information provided by (Responsible Party):
Ming Hou, Shandong University Identifier:
First received: September 3, 2012
Last updated: April 18, 2016
Last verified: September 2012
This study is designed to collect bone marrow and/or peripheral blood cells and plasma, for the analysis of adhesion molecules, chemokines and their receptors from newly-diagnosed aplastic anemia patients, and patients treated with antithymocyte globulin plus cyclosporine

Aplastic Anemia Healthy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Ming Hou, Shandong University:

Primary Outcome Measures:
  • hematologic response [ Time Frame: 6 months following antithymocyte globulin plus cyclosporine treatment ]
    hematologic response at 6 months following antithymocyte globulin plus cyclosporine treatment, defined as no longer meeting the criteria for severe aplastic anemia

Enrollment: 0
Study Start Date: February 2009
Estimated Study Completion Date: November 2012
Acquired Aplastic Anemia Patients Treated with Antithymocyte Globulin plus Cyclosporine


Ages Eligible for Study:   16 Years to 70 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients With Aplastic Anemia

Inclusion Criteria:

  • patients who fulfilled entry criteria of acquired aplastic anemia age range 16-70 years

Exclusion Criteria:

  • Patients complicated with diabetes, tumor, pregnancy, active infection, or connective tissue diseases, such as systemic lupus erythematosus.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01680055

China, Shandong
Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012
Sponsors and Collaborators
Shandong University
  More Information

Responsible Party: Ming Hou, Director, Shandong University Identifier: NCT01680055     History of Changes
Other Study ID Numbers: Aplastic Anemia 1
Study First Received: September 3, 2012
Last Updated: April 18, 2016

Additional relevant MeSH terms:
Anemia, Aplastic
Hematologic Diseases
Bone Marrow Diseases processed this record on August 17, 2017